(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.20%) $2 347.20
(-0.35%) $27.54
(0.17%) $922.10
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
3 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 12.91%
1.10% $ 11.92
Live Chart Being Loaded With Signals
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology...
Stats | |
---|---|
Объем за сегодня | 184 101 |
Средний объем | 369 315 |
Рыночная капитализация | 4.36B |
EPS | $0 ( 2024-02-21 ) |
Дата следующего отчета о доходах | ( $0.940 ) 2024-05-01 |
Last Dividend | $0.0970 ( 2010-08-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.37 |
ATR14 | $0.00900 (0.08%) |
Объем Корреляция
BAUSCH HEALTH COMPANIES Корреляция
10 Самые положительные корреляции | |
---|---|
HOM-UN.TO | 0.907 |
CJR-B.TO | 0.898 |
MTY.TO | 0.893 |
GOOS.TO | 0.885 |
ERO.TO | 0.882 |
LUN.TO | 0.88 |
LB.TO | 0.877 |
CARS.TO | 0.875 |
IGM.TO | 0.872 |
D-UN.TO | 0.871 |
10 Самые отрицательные корреляции | |
---|---|
QBTL.TO | -0.877 |
UNS.TO | -0.87 |
SBB.TO | -0.855 |
E.TO | -0.844 |
ABCT.TO | -0.836 |
SFC.TO | -0.822 |
THNC.TO | -0.822 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
BAUSCH HEALTH COMPANIES Корреляция - Валюта/Сырье
BAUSCH HEALTH COMPANIES Финансовые показатели
Annual | 2023 |
Выручка: | $8.76B |
Валовая прибыль: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2023 |
Выручка: | $8.76B |
Валовая прибыль: | $6.20B (70.78 %) |
EPS: | $-1.620 |
FY | 2022 |
Выручка: | $8.12B |
Валовая прибыль: | $5.76B (70.90 %) |
EPS: | $-0.590 |
FY | 2021 |
Выручка: | $8.43B |
Валовая прибыль: | $6.04B (71.61 %) |
EPS: | $-2.64 |
Financial Reports:
No articles found.
BAUSCH HEALTH COMPANIES Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.598 | 2005-11-28 |
Last Dividend | $0.0970 | 2010-08-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.49 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 4.74 | |
Div.Growth Potential Score | 3.23 | |
Div. Directional Score | 3.98 | -- |
Year | Amount | Yield |
---|---|---|
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ZCB.TO | Dividend Junior | 2023-06-28 | Quarterly | 7 | 1.72% | |
SFTC.TO | Dividend Knight | 2023-09-28 | Quarterly | 4 | 0.77% | |
HFG.TO | Dividend Knight | 2023-08-30 | Monthly | 5 | 3.22% | |
BND.TO | Dividend King | 2023-08-28 | Monthly | 9 | 2.30% | |
X.TO | Dividend King | 2023-08-10 | Quarterly | 22 | 6.21% | |
PBH.TO | Dividend Knight | 2023-09-28 | Quarterly | 17 | 1.70% | |
ENB-PA.TO | Dividend Knight | 2023-08-14 | Semi-Annually | 17 | 3.03% | |
ZJK.TO | Dividend King | 2023-08-29 | Monthly | 7 | 3.20% | |
TCW.TO | Dividend Knight | 2023-09-14 | Sporadic | 19 | 0.94% | |
IGM.TO | Dividend King | 2023-09-28 | Quarterly | 30 | 3.40% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0685 | 1.500 | -1.370 | -2.06 | [0 - 0.5] |
returnOnAssetsTTM | -0.0219 | 1.200 | -0.731 | -0.878 | [0 - 0.3] |
returnOnEquityTTM | 0.618 | 1.500 | 4.24 | 6.36 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.301 | 0.800 | 8.50 | 6.80 | [1 - 3] |
quickRatioTTM | 0.685 | 0.800 | -0.679 | -0.543 | [0.8 - 2.5] |
cashRatioTTM | 0.220 | 1.500 | 9.89 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.819 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0.725 | 1.000 | -0.843 | -0.843 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 8.85 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -21.91 | -1.500 | -10.00 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.708 | 1.000 | 1.537 | 1.537 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.110 | 1.000 | 9.80 | 9.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0489 | 1.000 | -0.839 | -0.839 | [0.2 - 2] |
assetTurnoverTTM | 0.320 | 0.800 | -1.199 | -0.959 | [0.5 - 2] |
Total Score | 4.74 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.15 | 1.000 | -0.622 | 0 | [1 - 100] |
returnOnEquityTTM | 0.618 | 2.50 | 6.30 | 6.36 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.30 | 2.00 | 9.23 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.09 | 2.00 | 8.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.143 | 1.500 | -4.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.125 | 1.000 | 9.37 | 0 | [0.1 - 0.5] |
Total Score | 3.23 |
BAUSCH HEALTH COMPANIES
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа